[Complementary and alternative medicine in urologic oncology].

Area of Science:

• Urooncology
• Evidence-based medicine
• Phytotherapeutics
• Homeopathic and anthroposophical medicines

Background:

• Phytotherapeutic, homeopathic, and anthroposophical medicines often have simplified licensing.
• Unlike conventional oncology drugs, some unconventional agents lack standard quality, side effect, and efficacy testing.
• Unconventional therapeutics are not equivalent to placebos and may have immunomodulatory effects.

Purpose of the Study:

• To evaluate the scientific evidence for unconventional medicines in urooncology.
• To assess the safety and efficacy of these agents against evidence-based medicine criteria.

Main Methods:

• Review of existing studies on unconventional treatments in urooncology.
• Analysis of data based on evidence-based medicine standards.
• Comparison with conventional oncology treatment protocols.

Main Results:

• Currently, no clear indication exists for the routine use of unconventional agents in urological oncology.
• Potential long-term adverse effects, including tumor progression, cannot be excluded due to immunomodulatory actions.
• A critical scientific evaluation is necessary.

Conclusions:

• Unconventional therapies in urooncology require rigorous scientific evaluation.
• Potential risks associated with immunomodulatory effects warrant caution.
• Evidence-based medicine criteria must guide treatment decisions in urological oncology.